BIENAIME JEAN JACQUES Insider Trading Activity

Average Profitability
51.36%
Insider Buys Quantity
42
Insider Buys Sum
$2.41M
Insider Sells Quantity
326
Insider Sells Sum
$276.78M

Insider Activity of BIENAIME JEAN JACQUES

According to the SEC Form 4 filings, BIENAIME JEAN JACQUES, being in a position of

  1. director at Ascendis Pharma A/S,
    оver the last 12 months, has bought 2900 shares for $699,337, and sold 0 shares,
    over all time since 2026-05-26, has bought 2900 shares for $699,337, and sold 0 shares.

Biography of BIENAIME JEAN JACQUES

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $1,126,5371393
Sells
 $203,82017

Comparison of Insiders on Amount of Buys and Sells

2026-08-17PurchaseKeros Therapeutics, Inc.
KROS
director
1,000
0.0049%
$10.27$10,270+6.97%
2026-08-14PurchaseAscendis Pharma A/S
ASND
director
2,000
0.0031%
$246.33$492,654-1.71%
2026-07-15PurchaseKeros Therapeutics, Inc.
KROS
director
1,000
0.003%
$10.61$10,610+0.68%
2026-06-15PurchaseKeros Therapeutics, Inc.
KROS
director
1,000
0.0031%
$10.19$10,190+8.15%
2026-06-05SaleImmunome, Inc.
IMNM
director
10,500
0.0115%
$19.41$203,820+21.56%
2026-06-05PurchaseImmunome, Inc.
IMNM
director
10,500
0.0115%
$19.45$204,260+21.56%
2026-05-29PurchaseAscendis Pharma A/S
ASND
director
500
0.0008%
$223.12$111,562+10.62%
2026-05-26PurchaseAscendis Pharma A/S
ASND
director
400
0.0007%
$237.80$95,121+3.29%
2026-05-15PurchaseImmunome, Inc.
IMNM
director
5,000
0.0052%
$20.70$103,500+6.23%
2026-05-15PurchaseKeros Therapeutics, Inc.
KROS
director
1,000
0.0031%
$10.58$10,580+5.1%
2026-04-15PurchaseKeros Therapeutics, Inc.
KROS
director
1,000
0.0027%
$11.70$11,700-5.21%
2026-03-11PurchaseImmunome, Inc.
IMNM
director
1,000
0.0011%
$21.55$21,550+3.74%
2026-03-10PurchaseImmunome, Inc.
IMNM
director
1,000
0.0012%
$22.12$22,120+1.56%
2026-03-09PurchaseKeros Therapeutics, Inc.
KROS
director
2,000
0.0053%
$11.21$22,420-2.07%
2025-06-03PurchaseImmunome, Inc.
IMNM
director
5,000
0.0058%
$9.38$46,900+101.4%
2025-03-25PurchaseImmunome, Inc.
IMNM
director
7,800
0.01%
$7.78$60,684+61.73%
2025-03-24PurchaseImmunome, Inc.
IMNM
director
7,000
0.0081%
$8.21$57,470+37.42%
2024-08-16PurchaseImmunome, Inc.
IMNM
director
7,000
0.0128%
$13.94$97,608-24.83%
2024-05-21PurchaseImmunome, Inc.
IMNM
director
2,000
0.0033%
$13.57$27,140-12.16%
2024-05-10SaleBioMarin Pharmaceutical Inc.
BMRN
director
20,000
0.0105%
$81.14$1.62M-13.49%
Total: 383
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.